Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II
Guidance for sponsors to notify enrollees who have utilized HCPs in the past six months that they may experience a rejection at the point of sale for HCPs on or after October 6, 2014 in light of this change in prescription requirements.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 18, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.